Page last updated: 2024-08-16

risedronic acid and chitosan

risedronic acid has been researched along with chitosan in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's7 (77.78)24.3611
2020's2 (22.22)2.80

Authors

AuthorsStudies
Benkő, E; Csüllög, A; Pintye-Hódi, K; Regdon, G; Sovány, T1
Khajuria, DK; Razdan, R; Zahra, SF1
Abbas, N; Bukhari, NI; Hussain, T; Karim, S; Shahzad, MK1
Anbu, J; Azamthulla, M; Banala, VT; Mukherjee, D; Ramachandra, SG; Srinivasan, B1
Abdelkhalek, AA; Morsi, NM; Nabil Shamma, R; Osama Eladawy, N1
Anbu, J; Mukherjee, D; Murahari, M; Santhosh, S; Teja, BV1
El-Laithy, HM; Elkady, OA; Tadros, MI1
Desai, J; Suthar, N; Thakkar, HP1
Abo El-Fadl, MT; Abouzeid, RE; Dufresne, A; El-Wakil, N; Kamel, R; Maged, A; Mahmoud, AA1

Other Studies

9 other study(ies) available for risedronic acid and chitosan

ArticleYear
Comparison of the properties of implantable matrices prepared from degradable and non-degradable polymers for bisphosphonate delivery.
    International journal of pharmaceutics, 2017, Nov-30, Volume: 533, Issue:2

    Topics: Bone Density Conservation Agents; Chitosan; Drug Delivery Systems; Drug Implants; Drug Liberation; Polyvinyl Chloride; Risedronic Acid; Tablets

2017
Effect of locally administered novel biodegradable chitosan based risedronate/zinc-hydroxyapatite intra-pocket dental film on alveolar bone density in rat model of periodontitis.
    Journal of biomaterials science. Polymer edition, 2018, Volume: 29, Issue:1

    Topics: Alveolar Bone Loss; Animals; Bone Density; Bone Density Conservation Agents; Chitosan; Drug Carriers; Drug Liberation; Durapatite; Osteocalcin; Osteoclasts; Periodontitis; Rats, Wistar; Risedronic Acid; Tartrate-Resistant Acid Phosphatase; Zinc

2018
RELATIVE BIOAVAILABILITY OF RISEDRONATE SODIUM ADMINISTERED IN SUPERABSORBENT COPOLYMER PARTICLES VERSUS ORAL SOLUTION TO NORMAL HEALTHY RABBITS.
    Acta poloniae pharmaceutica, 2016, Volume: 73, Issue:5

    Topics: Administration, Oral; Animals; Biological Availability; Chitosan; Drug Compounding; Methacrylates; Povidone; Rabbits; Risedronic Acid; Solutions; Succinates

2016
Improvement of bone microarchitecture in methylprednisolone induced rat model of osteoporosis by using thiolated chitosan-based risedronate mucoadhesive film.
    Drug development and industrial pharmacy, 2018, Volume: 44, Issue:11

    Topics: Animals; Bone and Bones; Chitosan; Disease Models, Animal; Drug Compounding; Female; Methylprednisolone; Microscopy, Electron, Scanning; Osteoporosis; Rats; Risedronic Acid; Spectroscopy, Fourier Transform Infrared; Thermogravimetry

2018
Bioactive injectable triple acting thermosensitive hydrogel enriched with nano-hydroxyapatite for bone regeneration: in-vitro characterization, Saos-2 cell line cell viability and osteogenic markers evaluation.
    Drug development and industrial pharmacy, 2019, Volume: 45, Issue:5

    Topics: Bone Cements; Bone Density Conservation Agents; Bone Regeneration; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chitosan; Drug Liberation; Durapatite; Glycerophosphates; Humans; Hydrogels; Materials Testing; Nanoparticles; Osteogenesis; Porosity; Risedronic Acid; Temperature; Tissue Engineering

2019
Improved treatment efficacy of risedronate functionalized chitosan nanoparticles in osteoporosis: formulation development, in vivo, and molecular modelling studies.
    Journal of microencapsulation, 2019, Volume: 36, Issue:4

    Topics: Animals; Bone Density; Bone Density Conservation Agents; Chitosan; Drug Carriers; Female; Nanoparticles; Osteoporosis; Rats, Wistar; Risedronic Acid

2019
QbD Approach for Novel Crosslinker-Free Ionotropic Gelation of Risedronate Sodium-Chitosan Nebulizable Microspheres: Optimization and Characterization.
    AAPS PharmSciTech, 2019, Dec-05, Volume: 21, Issue:1

    Topics: Animals; Biological Availability; Chitosan; Drug Delivery Systems; Drug Liberation; Gels; Male; Microspheres; Particle Size; Qualitative Research; Rats; Rats, Wistar; Risedronic Acid

2019
Investigation on Potential of Chitosan Nanoparticles for Oral Bioavailability Enhancement of Risedronate Sodium.
    AAPS PharmSciTech, 2021, Sep-17, Volume: 22, Issue:7

    Topics: Administration, Oral; Animals; Biological Availability; Chitosan; Drug Carriers; Nanoparticles; Particle Size; Rats; Risedronic Acid; Spectroscopy, Fourier Transform Infrared

2021
Risedronate-loaded aerogel scaffolds for bone regeneration.
    Drug delivery, 2023, Volume: 30, Issue:1

    Topics: Bone Regeneration; Cellulose; Chitosan; Risedronic Acid; Saccharum

2023